Announcements Trials
Browse Landscape

Phase

Phase 4 1Phase 2 1

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Rectal Neoplasms 2Sigmoid Neoplasms 1Erectile Dysfunction 1

Interventions

Fluorouracil 616Oxaliplatin 579Gemcitabine 492Capecitabine 445Leucovorin 427Irinotecan 390Bevacizumab 330Cisplatin 320Radiotherapy 245Cetuximab 215Sorafenib 167pembrolizumab 152Docetaxel 150Paclitaxel 140Nivolumab 128Albumin-Bound Paclitaxel 108130-nm albumin-bound paclitaxel 108Folfox protocol 101Panitumumab 95Erlotinib Hydrochloride 95Surgical Procedures, Operative 86regorafenib 84S 1 (combination) 81Drug Therapy 80Radiation 69Carboplatin 65Neoadjuvant Therapy 64Colonoscopy 64Radiosurgery 63Surveys and Questionnaires 60

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Completed × udenafil × Gastrointestinal × Clear all
NCT01421940 2015-03-10

The Efficacy of Penile Rehabilitation Using Udenafil After Total Mesorectal Excision of Rectal Cancer

Kyungpook National University Hospital

Phase 4 Completed
80 enrolled
Gastrointestinal

Rectal Neoplasms

NCT00607282 2012-09-05

Efficacy of Udenafil After Radical Resection for Sigmoid Colon and Rectal Cancer

Seoul National University Hospital

Phase 2 Completed
46 enrolled
Gastrointestinal

Erectile Dysfunction, Rectal Neoplasms, Sigmoid Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡